*The following content is generated by AI and is for reference only.
Overview
Dapagliflozin is a SGLT2 inhibitor API used for glycemic control. Synthesized via multi-step organic coupling, its molecular formula is C18H22ClNaO6S (CAS: 495720-08-0).
Application
- Pharmaceutical Manufacturing: Primary ingredient in oral tablets for Type 2 Diabetes.
- Cardiovascular Therapy: Indicated for heart failure management and renal protection.
- Research & Development: Used in clinical trials for metabolic syndrome studies.
Precautions
Contraindicated in severe renal impairment or hypersensitivity. Store in a dry environment below 25°C to prevent hydrolysis. Handle with PPE to avoid inhalation of dust particles.